This study was to examine the capacity of TYMS expression level in CRC cells in response to capecitabine cytotoxicity under obesity-visfatin stimulation and try to find a potential enhancer capacity of resveratrol in anti-CRC progression. Here, TYMS is linked to colorectal carcinoma.